Company Search:
Advanced Search
Sponsored Links
Aerie Pharmaceuticals Inc Company Snapshot
Aerie Pharmaceuticals Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Aerie Pharmaceuticals Inc with three other companies in this sector in the United States: Athersys, Incorporation (2018 sales of $24.29 million of which 100% was Biopharmaceutical), Quotient Ltd ($24.73 million of which 100% was Pharmaceutical Preparation), and Innovus Pharmaceuticals Inc ($23.99 million ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Aerie Pharmaceuticals Inc
  Stock Performance Chart for Aerie Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 19.23
(Figures in U.S. Dollars)
1 Week -21.0%   13 Weeks -4.6%  
4 Weeks -18.2%   52 Weeks -59.7%  
Aerie Pharmaceuticals Inc Key Data:
  Ticker: AERI Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 24,181,000
(Year Ending Jan 2019).
Employees: 353
  Currency: U.S. Dollars Market Cap: 884,559,924
  Fiscal Yr Ends: December Shares Outstanding: 45,998,956
  Share Type: Common Closely Held Shares: 4,766,582
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.